Startup Nation 2 Enterprise (SN2E), founded in 2014, is the 1st and only Startup Nation tech transfer company authorized by the Israeli Council for Higher Education to aggregate and commercialize IP developed at Israeli government-funded academic institutions, hospitals and research centers. SN2E is led by seasoned Tech entrepreneurs and business managers with decades of cumulative experience in a wide range of industries, markets and IP transfer knowledge. SN2E is rapidly scaling to be the world’s leading IP marketplace with an Israel government mandate to represent up to 45 leading Startup Nation academic institutions, hospitals and research centers and their commercializable IP and know-how in a wide range of scientific fields. SN2E receives millions of dollars in government grants to accelerate IP development in the research institutions it represents.
SN2E delivers a constant flow of commercially ready IP opportunities. Today, SN2E has dozens of IP ready for industry growth applications, hundreds of IP’s in the development pipeline, and thousands of Startup Nation researchers from leading Israeli institutes across the widest range of industry use cases available to apply their technological know-how to industry growth needs.
The SN2E INFORMED IP MEMBER end-to-end customer-centric IP commercialization process and Startup Nation IP pipeline, create an unprecedented direct and fast connection between Israel’s leading researchers and multi-national Fortune 1,000 corporation Innovation, M&A and Ventures Executives to identify business growth needs and strategic IP solutions more efficiently than current TTO models.
Startup Nation Technology Transfer Leader
SN2E leads in uncovering commercially promising inventions and knowledge developed in Israeli’s leading colleges and government-owned hospitals and research centers. This area of academia is a rich source of practical IP, ready for accelerated development into high-value products. SN2E provides a direct route to opportunities in a vast array of fields with a customer-centric IP development and transfer commercialization process accompanied by world-class white-glove services.
SN2E partners enjoy equity-free government subsidies, a fast and assured route to technology transfer, and access to an extensive network of contacts across the spectrum of Israel’s scientific, business and financial communities. SN2E provides a constant flow of commercializable IP opportunities.
Single Source Startup Nation IP Partner
SN2E has built a team of highly experienced global business, sales, technology, IP lawyers, Fortune 500 Chief Marketing Officer and innovation executives from a broad range of industries. Our experts are on-the-ground in Israel and North America to be of service to our Fortune 1,000 IP customers 45 IP institutions. SN2E provides a highly efficient, white-glove service to complete solutions for licensing technology and transforming IP into commercial success. With its business-oriented approach, multi-disciplinary experts team, end-to-end workflow and patent-pending practical IP discovery methodology, SN2E brings unique value to every step of the invention protection process while enabling fast Return on Innovation for all parties.
SN2E employs an in-house developed methodology for commercialization of Intellectual Properties (IP). The methodology, also known as Application Specific Intellectual Property (ASIP), ensures a predictable transformation of a scientific discoveries and inventions from the field of academic research all the way to a volume production deployment of the IP related technology into a commercially viable product.
SN2E provides a highly efficient, complete solution for transforming IP into commercial success. With its business-oriented approach, multi-disciplinary expert team, end-to-end workflow and unique practical IP discovery methodology, SN2E brings unique value to every step of the process, enabling fast ROI for all parties.
SN2E follows a unique end-to-end workflow for identifying promising inventions, evaluating commercial applications, and matching opportunities to investment goals. Its proprietary Application Specific IP (ASIP) methodology ensures predictable transformation of scientific discoveries and inventions into commercially viable products and fast ROI.
“The innovation going on in Israel is critical to the future of the technology business.” – Bill Gates, Founder of Microsoft